Phase 4 Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with schizophrenia or schizoaffective disorder based on a specific set of standard diagnostic guidelines (called DSM-IV criteria)
- People who are being treated as outpatients (not currently staying in a hospital)
- People who are 18 years of age or older
- People who have been taking clozapine twice a day (with one dose in the evening or at bedtime) at the same dose and schedule for at least 3 months
- People who are fluent in English and able to understand and sign a written consent form
Who may not be able to join:
- People who have a significant medical or neurological illness (confirm with trial site)
- People who are pregnant or currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gary Remington, MD, PhD, Centre for Addiction and Mental Health
Phone: +1-416-535-8501
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Brief Psychiatric Rating 18 item Scale (BPRS 18 item scale)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.